Kairos Pharma Ratios (2024-2025) | KAPA

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Profitability
EBT Margin 1,893.75%1,950.00%171.32%-1.26%
EBIT Margin 1,793.75%1,850.00%71.32%-1.27%
EBITDA Margin 1,793.75%1,850.00%71.32%-1.27%
Operating Margin 1,793.75%1,850.00%71.32%-1.27%
Net Margin 1,893.75%1,950.00%171.32%-1.26%
FCF Margin -225.00%1,400.00%376.16%-0.71%
Efficiency
Assets Average 5.39M6.85M7.30M
Equity Average 4.05M5.95M6.56M
Invested Capital 3.33M4.78M7.13M6.00M
Asset Utilization Ratio -0.1014.5113.62
Leverage & Solvency
Interest Coverage Ratio -17.94-18.50-0.71-10.87
Equity Ratio 0.670.830.900.90
Times Interest Earned -17.94-18.50-0.71-10.87
Valuation
Enterprise Value -3.22M-3.62M-3.03M
Return Ratios
Return on Sales 18.94%19.50%1.71%5.37%-0.01%-0.05%
Return on Capital Employed -0.53%-0.55%-0.69%
Return on Assets -0.56%-0.58%-0.71%
Return on Equity -0.75%-0.67%-0.79%